Skip to main content
Premium Trial:

Request an Annual Quote

CS-Keys, Power3 Medical Products, Cohen Independent Research Group, Cellzome, Galapagos, BBSRC, GeneBio, SIB, Thermo Electron, GV Instruments, Entelechon


Proteomic Startup CS-Keys Attracts VC Seed Funding

Indianapolis-based CS-Keys received an investment from Triathlon Medical Ventures, the second investment CS has received since its creation in 2005, the company said this week.

The amount of the investment was not disclosed.

CS-Keys will use the funds to continue research and development of cancer-specific biomarkers and for marketing and regulatory strategies of the company.

Earlier this year, CS received a $285,000 investment from the Indiana Seed Fund.

Cohen Independent Research Group Initiates Coverage of Power3

Power3 Medical Products said this week that the Cohen Independent Research Group has initiated coverage of its stock.

Cohen has a strong record with companies that have not had analyst coverage, Power3 said.

Report Predicts $1.4B Mass Spec Market by 2011

Technological advances and the greater use of mass spectrometers in clinical settings will continue the growth in use of mass spectrometry, according to a report by market research firm Frost & Sullivan.

According to the report, "US Life Science Mass Spectrometry Markets," MS industry revenues totaled $695.7 million in 2005 and may reach $1.39 billion in six years.

Cellzome Partners with Galapagos on Kinase Drug Discovery

Cellzome will have access to Galapagos' SoftFocus kinase libraries under an agreement the companies announced this week.

The companies will use Cellzome's proprietary proteomics technology, Kinobeads, to screen the libraries in order to identify inhibitors against inflammatory kinases.

Galapagos will also provide biological screening and chemistry expertise to find inhibitors in Cellzome's kinase targets.

Galapagos' service division will receive an upfront payment and research fees under the agreement. Other financial terms were not disclosed.

UK's BBSRC Launches Training Courses for Proteomics-Related Bioinformatics

The UK's Biotechnology and Biological Sciences Research Council has allocated £500,000 ($921,000) to launch a series of courses under the title of "Proteomics and e-Science Training."

The initiative funds four courses: Practical Proteomics, Application of Bioinformatics to Proteomics, Bioinformatics for High Throughput Proteomics, and Proteomics Data Management for Bioscientists.

Further details on the program are available at

GeneBio and SIB Collaborate on Web-Based Proteomics Training Portal

Geneva Bioinformatics and the Swiss Institute of Bioinformatics have signed an agreement under which GeneBio's e-Proxemis proteomics portal will become the "centralized educational platform" for SIB's ExPASy server.

The e-Proxemis portal is a web-based bioinformatics resource that offers a number of tutorials and enables users to advance through increasingly demanding scenarios and case studies, GeneBio said.

Thermo Electron Buys GV Instruments, Adding Noble Gas Isotope MS

Thermo Electron has purchased GV Instruments Limited of Manchester, UK, a manufacturer of isotope ratio mass spectrometers, for approximately $21 million subject to a post-closing adjustment.

The purchase expands Thermo's offerings in high precision isotope ratio determination. In particular GV will add the capability of noble gas isotope mass spectrometry, the companies said in a press release.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.